Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical goods.
| Ratio | 2023 | 2024 |
|---|---|---|
| Margins | ||
| Gross Margin | 63.4% | 60.8% |
| EBITDA Margin | 61.9% | 56.4% |
| EBITDAR | 4,117 | 1,673 |
| EBITDAR Margin | 61.9% | 56.9% |
| EBIT Margin | 61.9% | 56.4% |
| Net Profit Margin | 62.9% | 59.8% |
| Operating Expense % of Sales | 1.4% | 4.4% |
| Returns | ||
| Return on Assets (ROA) | 163.5% | 65.6% |
| Return on Equity (ROE) | 173.1% | 77.0% |
| ROIC [EBIT / Invested Capital] | 169.8% | 77.0% |
| Leverage & debt balances | ||
| Debt-to-Assets | 0.3% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x |
| Equity-to-Assets | 94.4% | 85.1% |
| Net Debt | 8 | -134 |
| Cash & Equivalents | 0 | 134 |
| Total Debt | 8 | N/A |
| Liquidity & working capital | ||
| Current Ratio | 18.01x | 6.72x |
| Quick Ratio | 18.01x | 6.72x |
| Cash Ratio | 0.00x | 0.33x |
| Total Current Assets | 2,558 | 2,686 |
| Total Current Liabilities | 142 | 400 |
| Inventory | N/A | N/A |
| Trade Receivables | 2,473 | 2,543 |
| Trade Payables | 134 | 399 |
| Net Working Capital | 2,416 | 2,286 |
| Net Working Capital % of Revenue | 36.3% | 77.7% |
| Trade Working Capital | 2,339 | 2,144 |
| Trade Working Capital % of Revenue | 35.2% | 72.9% |
| Change in Trade Working Capital | N/A | -195 |
| Turnover & efficiency | ||
| Inventory Turnover | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A |
| Receivables Turnover | 2.69x | 1.16x |
| Days Sales Outstanding (DSO) | 135.7 | 315.4 |
| Payables Turnover | 18.25x | 2.89x |
| Days Payable Outstanding (DPO) | 20.0 | 126.1 |
| Cash Conversion Cycle | 115.7 days | 189.4 days |
| Asset Turnover | 2.60x | 1.10x |
| Cash flow & dividends | ||
| Operating Cash Flow | 1,766 | 2,028 |
| Free Cash Flow (OCF − Capex proxy) | 1,766 | 2,028 |
| Cash Conversion (OCF / EBITDA) | 42.9% | 122.3% |
| Dividends Declared | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →